Canadian landmarks light up in red and white, but the true brightness comes from stories of survival, support, and hope — like Michelle’s.
Michelle came to Canada from the Philippines, full of promise, only to be faced with one of the world’s deadliest infections: tuberculous meningitis, a drug-resistant form of tuberculosis (TB). With determination, a dedicated team of health professionals, and Canada’s world-class TB care system, Michelle survived. But her story isn’t just about luck — it’s about what’s possible when a community comes together to fight a disease that still kills over 3,000 people every single day.
At TB Vets, we know that it takes a village to save lives — and our community of donors is part of that village.
“Until controlled globally, TB will continue to impact us locally.” – Dr. William Connors
While TB might feel like a distant threat to some, it’s very real right here at home. Thousands of people in Canada are diagnosed with TB every year, the majority of them immigrants. It’s a clear reminder that TB anywhere is TB everywhere. And as cases rise again globally — driven by the ripple effects of COVID and funding cuts — the urgency to act has never been greater.
That’s why TB Vets supports some of the brightest scientific minds fighting this ancient disease. Among them:
Dr. Yossef Av-Gay, who studies how Mycobacterium tuberculosis (Mtb) grows and survives inside human macrophages and Dr. James Johson who is working on studying TB biomarkers.
These are not just academic efforts; they’re life-saving breakthroughs in the making. Your donations help fuel this critical research. When you give to TB Vets, you help Canada stay at the forefront of TB innovation — both in treatment and prevention.
The reality is stark: we’re at a crossroads in the global fight against TB. But stories like Michelle’s — and the incredible work of Canadian researchers — show us that with the right support, we can rewrite the future.
Together, we can build a world where TB is no longer the No. 1 infectious disease killer.
